|
|
| |
 |
Search Results  glaxosmithkline pharamaceuticals |
|
|
| |
| 'GSK India will outpace industry growth' | 06-APR-09 |
|
| The Rs 1,660 crore Indian subsidiary of pharma giant GlaxoSmithkline Pharamaceuticals is banking on new product launches (such as the anti-cancer drug Tykerb launched last year) and penetration into smaller towns to boost revenue growth. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
| |
 |
Most Popular |
|
|
|
|
|
|
|
|
|
|
|
| |
 |
Hot Searches |
|
|
|
|
|
|
|
|
|
|
|
|
Content Guide
